| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |